Alembic Pharmaceuticals Limited (NSE:APLLTD)
1,044.00
+14.05 (1.36%)
Nov 12, 2026, 3:29 PM IST
Alembic Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Alembic Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹1,076. The average 1-year stock price forecast is 3.06% higher than the current stock price, while the lowest is ₹895.00 (-14.27%) and the highest is ₹1,272 (+21.84%).
Price Target: ₹1,076 (+3.06%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alembic Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Financial Forecast
Revenue This Year
90.66B
from 73.45B
Increased by 23.43%
Revenue Next Year
96.62B
from 90.66B
Increased by 6.57%
EPS This Year
45.29
from 37.62
Increased by 20.37%
EPS Next Year
52.26
from 45.29
Increased by 15.39%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.